X0306 4 2018-06-19 0 0001631650 Aimmune Therapeutics, Inc. AIMT 0001650322 Dallas Jayson Donald Alexander C/O AIMMUNE THERAPEUTICS, INC. 8000 MARINA BOULEVARD, SUITE 300 BRISBANE CA 94005-1884 1 1 0 0 President and CEO Common Stock, $0.0001 par value 2018-06-19 4 A 0 60000 0.00 A 60000 D Stock Option (right to buy) 30.68 2018-06-19 4 A 0 350000 0.00 A 2028-06-19 Common Stock 350000 350000 D These shares represent restricted stock units ("RSUs") and will be settled in common stock upon vesting. The RSUs vest in four successive, equal, annual installments measured from June 19, 2018, subject to the Reporting Person's continued service relationship with the Issuer on each such vesting date. The shares subject to the option will vest and become exercisable as to 25% of the total number of shares subject to the option on June 19, 2019 and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued service relationship with the Issuer on each such vesting date. /s/ Douglas T. Sheehy, as Attorney-in-Fact for Jayson Donald Alexander Dallas 2018-06-19